Sign in

CIK 0001367083

  • Non-accelerated filer
  • Smaller reporting company

Sonoma Pharmaceuticals, Inc.

Sign in to watch
Ticker
SNOA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
680423298
Phone
+1 800-759-9305
Business address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
Former names
Oculus Innovative Sciences, Inc.
  1. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $4.86 ($24,300)
  2. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $4.88 ($4,880)
  3. 4 Grant or award Chief Executive Officer acquired 3,535 shares (grant or award)
  4. 4 Grant or award Exec. VP of Res & Devlpment acquired 4,678 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 15,593 shares (grant or award)
  6. 4 Grant or award Director acquired 1,423 shares (grant or award)
  7. 4 Grant or award Director acquired 1,229 shares (grant or award)
  8. 4 Grant or award Director acquired 841 shares (grant or award)
  9. 4 Grant or award Director acquired 1,035 shares (grant or award)
  10. 4 Grant or award Director acquired 1,648 shares (grant or award)
  11. 4 Grant or award Director acquired 1,423 shares (grant or award)
  12. 4 Grant or award Director acquired 974 shares (grant or award)
  13. 4 Grant or award Director acquired 1,199 shares (grant or award)
  14. 4 Open-market buy Chief Executive Officer bought 1,328 shares at $3.66 ($4,866)
  15. 4 Grant or award Director acquired 6,765 shares (grant or award)
  16. 4 Grant or award Director acquired 5,090 shares (grant or award)
  17. 4 Grant or award Director acquired 4,188 shares (grant or award)
  18. 4 Grant or award Director acquired 4,445 shares (grant or award)
  19. 4 Grant or award Director acquired 17,878 shares (grant or award)
  20. 4 Grant or award Director acquired 16,237 shares (grant or award)

Page 7 of 16 · 317 filings